The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis

Journal of Clinical Investigation

Volumn 99, Issue 12, 1997, Pages 2950-2960

  Johnson, Timothy S ^a   Griffin, Martin ^b   Thomas, Graham L ^a   Skill, James ^b   Cox, Ann ^b   Yang, Bin ^a   Nicholas, Ben ^b   Birckbichler, Paul J ^c   Muchaneta Kubara, Chiwoneso ^a   El Nahas, A Meguid ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Kidney; Scarring; Subtotal nephrectomy; Tubule; ( glutamyl) lysine

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SCLEROPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CROSS LINKING; DISEASE COURSE; ENZYME ACTIVITY; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY TUBULE; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; SCAR FORMATION;

EID: 0030986772     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119490     Document Type: Article

References (53)

1. Floege, J., R.J. Johnson, K. Gordon, A. Yoshimura, C. Cambell, L. IrueaAripse, C.E. Alpers, and W.G. Couser. 1992. Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy. Kidney Int. 42: 573-585.
2. Peten, E.P., L.J. Stricker, M.A. Carome, S.J. Elliott, C.W. Yang, and G.E. Striker. 1992. The contribution of increased collagen synthesis to human glomerulosclerosis. A quantitative analysis of α(2) IV collagen mRNA expression by competitive polymerase chain reaction. J. Exp. Med 176:1571-1576.
3. Jones, C.L., S. Buch, M. Post, L. McCulloch, E. Liu, and A.A. Eddy. 1991. Renal extracellular matrix accumulation in acute purine aminonucleoside nephrosis in rats. Am. J. Pathol. 135:719-733.
4. Eddy, A.A., and C.M. Giachelli. 1995. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein overload proteinuria. Kidney Int. 47:1546-1557.
5. Griffin, M., L.L. Smith, and J. Wynne. 1979. Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induce by paraquat. Br. J. Exp. Pathol. 60:653-661.
6. Bowness, J.M., A.H. Tarr, and R.I. Wiebe. 1989. Transglutaminase-catalysed cross-linking: a potential mechanism for the interaction of fibrinogen, low density lipoprotein and arterial type III procollagen. Thromb. Res. 54:357-367.
7. Bowness, J.M., and A.H. Tarr. 1990. Lipoprotein binding of crosslinked type III collagen aminopropeptide and fractions of its antigen in blood. Biochem. Biophys. Res. Commun. 170:519-524.
8. Bowness, J.M., M. Venditti, A.M. Tarr, and J.R. Taylor. 1994. Increase in epsilon (gamma-glutamyl) lysine crosslinks in atherosclerotic aortas. Atherosclerosis. 111:247-253.
9. Folk, J.E., and J.E. Finlayson. 1977. The ε(γ-glutamyl) lysine crosslink and the catalytic role of transglutaminase. Adv. Prot. Chem. 31:1-133.
10. Folk, J.E. 1980. Transglutaminases. Annu. Rev. Biochem. 49:517-531.
11. Fesus, L., V. Thomazy, F. Autuori, M.P. Ceru, E. Tarcsa, and M. Piacentini. 1989. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett. 245:150-154.
12. Fesus, L., P.J.A. Davies, and M. Piacentini. 1991: Apoptosis - molecular mechanisms in programmed cellular death. Eur. J. Cell Biol. 56:170-177.
13. Lorand, L., and S.M. Conrad. 1984. Transglutaminases. Mol. Cell Biochem. 58:9-35.
14. Rice, R.H., and H. Green. 1977. The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross linked protein. Cell. 11:417-422.
15. Greenberg, C.S., P.J. Birckbichler, and R.H. Rice. 1991. Transglutaminases: Multifunctional enzymes that stabilise tissues. FASEB (Fed. Am. Soc. Exp. Biol.) J. 5:3071-3077.
16. Fesus, L., V. Thomazy, and A. Falus. 1987. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224:104-108.
17. Knight, C.R.L., R.C. Rees, and M. Griffin. 1991. Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim. Biophys. Acta. 1096:312-318.
18. Knight, C.R.L., D. Hand, M. Piacentini, and M. Griffin. 1993. Characterisation of the transglutaminase-mediated large molecular weight polymer from rat liver: its relationship to apoptosis. Eur. J. Cell Biol. 60:210-216.
19. Cai, D., T. Ben, and L.M. De Luca. 1991. Retinoids induce tissue transglutaminase in NIH-3T3 cells. Biochem. Biophys. Res. Commun. 175:1119-1124.
20. Bowness, J.M., J.E. Folk, and R. Timpl. 1987. Identification of a substrate for liver transglutaminase on the aminopropeptide of type III collagen. J. Biol. Chem. 262:1022-1024.
21. Aeschlimann, D., and M. Paulsson. 1991. Crosslinking of laminin-nidogen complexes by tissue transglutaminase: a novel mechanism for basement membrane stabilisation. J. Biol. Chem. 266:15308-15317.
22. Kleman, J.P., D. Aeschlimann, M. Paulsson, and M. Van der rest. 1995. Transglutaminase-catalysed cross linking of fibrills of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry. 34:13768-13775.
23. 2+-treated lens. Investig. Ophthalmol. Vis. Sci. 28:1218-1222.
24. Selkoe, D.J., C. Abraham, and Y. Ihara. 1982. Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers: Proc. Natl. Acad. Sci. USA. 79:6070-6074.
25. Dudek, S.M., and G.J. Johnson. 1993. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau. J. Neurochem. 62:1159-1162.
26. El Nahas, A.M., A.H. Bassett, G.H. Cope, and J.E. Le Carpentier. 1991. Role of growth hormone in the development of experimental renal scarring. Kidney Int. 40:29-34.
27. Weibel, E.R. 1979. Stereological Methods: Practical Methods for Biological Morphometry. Vol. I. London Academic Press. 1-415.
28. 4. Nature (Lond). 227:680-685.
29. Knight, C.R.L., R.E. Rees, B.M. Elliott, and M. Griffin. 1990. The existence of an inactive form of transglutaminase within metastasising tumours. Biochim. Biophys. Acta. 1053:13-21.
30. Birckbichler, P.J., H.F. Upchurch, and E. Conway. 1985. A monoclonal antibody to cellular transglutaminase. Hybridoma. 4:179-186.
31. -ε γ-glutamyl lysine isopeptide levels during cell growth: an enzymic immunological study. Int. J. Cancer. 48:221-226.
32. Griffin, M., and J. Wilson. 1984. Detection of ε(γ-glutamyl) lysine. mol. Cell Biochem. 58:37-49.
33. Cohen, G.M., X.M. Sun, H. Fearnhead, M. MacFarlane, D.G. Brown, R.T. Snowden, and D. Dinsdale. 1994. Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J. Immunol. 153:507-516.
34. Schlze-Osthoff, K., M.K.A. Bauer, M. Vogt, and L. Los. 1996. Role of ICE related and other proteases in Fas mediated apoptosis. Cell Death and Differentiation. 3:177-184.
35. Riemenschneider, T., S. Mackensen-Haen, H. Christ, and A. Bohle. 1980. Correlation between endogenous creatinine clearance and relative interstitial volume of the renal cortex in patients with diffuse membranous glomerulonephritis having a normal serum creatinine concentration. Lab. Invest. 43: 145-149.
36. Jeong, J.M., S.N.P. Murthy, J.T. Radek, and L. Lorand. 1995. The fibronectin binding domain of transglulaminase. J. Biol. Chem. 270:5654-5658.
37. Birkedal-Hanson, H., W.G. Moore, and M.K. Bodden. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4:197-250.
38. Kojima, S., K. Nara, and D. Rifkin. 1993. Requirement for transglutaminase in the activation of latent transforming growth factor β in bovine endothelial cells. J. Cell Biol. 121:439-448.
39. Johnson, T.S., C.R.L. Knight, S. El-Alaoui, S. Mian, R.C. Rees, V. Gentile, P.J.A. Davies, and M. Griffin. 1994. Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth. Oncogene. 9:2935-2942.
40. Aeschlimann, D., P. Kaupp, and M. Paulsson. 1995. Transglutaminase crosslinking in differentiating cartilage. Identification of osteonectin as a major glutaminyl substrate. J. Cell Biol. 129:881-892.
41. George, M.D., M. Thomas, E. Volberg, E. Floyd, J.P. Stein, and A.M. Jetten. 1990. Regulation of transglutaminase type II by transforming growth factor β1 in normal and transformed human epidermal keratinocytes. J. Biol. Chem. 265:11098-11104.
42. Border, W.A., and N.A. Noble. 1993. Cytokines in kidney disease: the role of transforming growth factor-beta. Am. J. Kidney Diseases. 22:105-113.
43. Ando, T., S. Okuda, K. Tamaki, K. Yoshitomi, and M. Fujishima. 1995. Localisation of transforming growth factor β and latent transforming growth factor β binding protein in rat kidney. Kidney Int. 47:733-739.
44. Basile, D.P., J.M. Rovak, D.R. Martin, and M.R. Hammerman. 1996. Increased transforming growth factor β1 expression in regenerating rat renal tubule following ischemic injury. Am. J. Physiol. 270:F500-F509.
45. Cambell, R. 1987. Polyamines and uraemia. Adv. Exp. Med. Biol. 223: 47-55.
46. Sugiyama, H., N. Kashihara, H. Makino, Y. Yamasaki, and Z. Ota. 1996. Apoptosis in glomerular sclerosis. Kidney Int. 49:103-111.
47. Upchurch, H.F., E. Conway, M.K. Patterson, Jr., and M.D. Maxwell. 1991. Localisation of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme. J. Cell Physiol. 149: 375-382.
48. Bowness, J.M., A.H. Tarr, and T. Wong. 1988. Increased transglutami-nase activity during skin wound healing in rats. Biochim. Biophys. Acta. 967: 234-240.
49. Greenberg, C.S., K.E. Achyuthan, M.J. Borowitz, and M.A. Shuman. 1987. The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilisation. Blood. 70:702-709.
50. Billett, H.H., and E.G., Puszkin. 1991. The red cell membrane contains calmodulin-regulated crosslinking and proteolytic activity. Hematol. Pathol. 5: 185-193.
51. Dolynchuk, K.N., R. Bendor-Samuel, and J.M. Bowness. 1994. Effect of putrescine on tissue transglutaminase activity in wounds: decreased breaking strength and increased matrix fucoprotein solubility. Plast. Reconstr. Surg. 93: 567-573.
52. Hornyak, T.J., and J.A. Shafer. 1992. Interactions of factor XIII with fibrin as substrate and cofactor. Biochemistry. 31:423-429.
53. Howie, A.J., B.K. Gunson, and J. Sparke. 1990. Morphometric correlates of renal excretory function. J. Pathol. 160:245-253.